Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COM SHS
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
413K
-
Shares change
-
+77.4K
-
Total reported value, excl. options
-
$2.54M
-
Value change
-
+$489K
-
Number of buys
-
7
-
Number of sells
-
-10
-
Price
-
$6.16
Significant Holders of Serina Therapeutics, Inc. - COM SHS (SER) as of Q2 2025
28 filings reported holding SER - Serina Therapeutics, Inc. - COM SHS as of Q2 2025.
Serina Therapeutics, Inc. - COM SHS (SER) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 413K shares
.
Largest 10 shareholders include VANGUARD GROUP INC (151K shares), BROADWOOD CAPITAL INC (85.2K shares), Waverly Advisors, LLC (67.5K shares), GEODE CAPITAL MANAGEMENT, LLC (28.9K shares), HighTower Advisors, LLC (17.9K shares), Keel Point, LLC (17.8K shares), NORTHERN TRUST CORP (16.5K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (13.2K shares), BlackRock, Inc. (11.8K shares), and TORONTO DOMINION BANK (3.55K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.